This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For some perspective on the matter, Project CBD turned to Marc Scialdone, a molecular chemist with Saint Michaels College in Vermont, who co-authored a 2023 paper for the International Cannabinoid Research Society ( ICRS ) entitled The Dark Side of Cannabidiol. Devitt expresses serious safety concerns. “The market crashed.
"This bill will facilitate trusted university partners to engage in the kinds of research that will best equip state and federal lawmakers and regulators to develop effective cannabis policies based on public health and safety, will allow consumers to make more informed choices, and will help train the next generation of cannabis researchers."
The Office of Drug Control (ODC) issues several license types, including: Cultivation growing cannabis for medicinal or research purposes. Research studying cannabis for medicinal development. Businesses should also investigate potential research and development (R&D) incentives if applicable.
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.
Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?
It is quite common for cannabis researchers to make use of vertebrates since animals with spines have an endocannabinoid system (ECS), such as mice and rats. Cats do have an ECS, but why use them for research*? As the team stated, aging cats develop cognitive dysfunction as they become older, much like humans.
Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A press release announcing the scientists’ research explains that the team has “designed two new compounds that can relieve depression but do not cause the unwanted effect of hallucination.” A New Kind of Depression Treatment.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety. A Vicious Circle. .
The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. .
In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.
While many have speculated that the skunk smell could be attributed to the terpenes , or aromatic compounds, of cannabis, the research team behind the study actually discovered a whole new class of volatile sulfur compounds (VSCs) to thank for the cannabis-skunk phenomenon. Studying the Chemical Makeup of Cannabis. Super Skunk. Sour Diesel.
(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.
Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. In 2008, he published psychedelic safety guidelines.
5, 1930, “the father of cannabis research” was born. From the Black Sea-encapsulated mountainous terrain of Bulgaria, Professor Raphael Mechoulam immigrated to Israel, where he would make a legendary name for himself as a pioneer in medical cannabis research. Had it not been for Prof.
From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. with unknown pharmacological and safety profiles.” End cannabis prohibition, the market for these products will go away and these compounds will be relegated to research labs, where they belong, not the marketplace.
There is little relationship between blood or saliva limits on cannabis-impaired driving and the driver’s actual impairment, and law enforcement authorities must develop new detection methods, according to the findings of a new study. They also found that even 3.5 A ‘pressing need’ for better cannabis intoxication, impairment tests.
A Swinburne study into the effects on medical cannabis on driving ability has received $358,980 in funding from the federal government’s Road Safety Innovation Fund. The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. Our research.
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.
Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. However, the existing legal environment significantly hinders the ability of clinicians to engage with cannabis research or offer clear guidance. lags behind other nations.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Biotech startup to bring safety and efficacy to the emerging psychedelic industry, brings on University of Michigan Researcher as Chief Science Officer. Nearly all forms of research being done on psychedelics are via the digestive tract, which slows uptake, requires higher dosage, and may lead to harmful side effects in the body.
This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. In response, veterinarians and others concerned for patient safety promoted a change in state law. Related story.
SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. The company has begun preparation that will facilitate the commencement of the clinical study and engaged with a contract research organization (CRO) to provide support for the trial.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.
According to an August 2019 report released by Grand View Research, Inc., We’ll continue to update you on any other regulatory development via this blog. As the first national retailer to adopt CBD guidelines, Sephora is raising the need to assist consumers in navigating this complex regulatory landscape.
Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. There is a possibility for local jurisdictions to “opt out.”.
Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study abstract is available here. The methods for both phases were the same.
But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. Interesting piece from Lucid news. Read the full report at .
Cannabis research related to PTSD (post-traumatic stress disorder) is a growing field. We continue to learn more and more as research funding is becoming available and laws are allowing for more studies to be conducted. Some researchers hypothesize that cannabis could potentially help modulate this system to alleviate PTSD symptoms.
According to UC Berkeley’s Department of Environmental Science Policy and Management researchers, California’s cannabis crops are threatened by wildfires more than any other crop. . UC Berkeley researchers assessed the level of wildlife risk faced by licensed cannabis farms in 11 counties that produce the plant in large quantities.
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
Rather, it’s a modest bipartisan piece of legislation that’s simply meant to promote research into marijuana. JUST IN: The Senate passed my bill with Senators Grassley and Schatz to cut red tape around the research process of marijuana and marijuana-derived medications. — Senator Dianne Feinstein (@SenFeinstein) March 24, 2022.
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Once known solely as a party drug, ketamine is starting to earn a new reputation thanks to research efforts into its potentially medicinal qualities.
However, research on the specific benefits and effects of THCjd is still in the works. However, due to its legal status and limited research, it is necessary to exercise caution and comply with local regulations when considering its use. It’s also worth mentioning that the safety of THCjd depends on various factors.
Gold Country Development, LLC v. Marconi, formed Gold Country Development, LLC, also a plaintiff. Plaintiffs purchased 237 acres of land in El Dorado County to research and grow hemp. Plaintiffs purchased certified hemp seeds under the LLC as an Established Agricultural Research Institution (EARI). County of El Dorado.
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ?9-tetrahydrocannabinol for beta testing.
WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . Pivoting on New Product Development. . WHERE: Register here.
Research has indicated that cannabinoids might have antitumor properties. One particular cannabis concentrate that has been gaining attention in the realm of skin cancer treatments is Rick Simpson Oil (RSO) , a concentrated form of cannabis oil that was developed by Rick Simpson, a Canadian medical marijuana activist.
OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S. The company’s efforts to secure patents are the cornerstone of its strategy to develop and license therapeutics. Silo Pharma Inc. Bringing Products to Market.
–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. Monrovia-Based Lab Acquisition Strengthens Cannabis Testing In California.
Ethics, Safety, and Abuse in Psychedelic Medicine. Allison Feduccia, PhD is a neuropharmacologist, psychedelic researcher, and a builder of virtual and in-person communities. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS.
On the heels of the Illinois Supreme Court recently hearing oral arguments about aroma as lone probable cause for a vehicle search and supreme court judges commenting on cannabis-impaired drivers and public safety, Illinois Rep. After its first reading, HB4890 was referred to the Rules Committee.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content